Non-homogeneous effect of levodopa on inhibitory circuits in Parkinson's disease and dyskinesia

Parkinsonism and Related Disorders

Volumn 19, Issue 2, 2013, Pages 165-170

  Barbin, Laetitia ^a,b   Leux, Christophe ^b   Sauleau, Paul ^b,c   Meyniel, Claire ^a,b,d   Nguyen, Jean Michel ^b,d   Pereon, Yann ^b,d   Damier, Philippe ^a,b,d  

^a INSERM   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c RENNES UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ DE NANTES   (France)

Author keywords

Dyskinesia; Inhibition; Parkinson's disease; Plasticity; Transmagnetic stimulation

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFECT; DYSKINESIA; EVOKED MUSCLE RESPONSE; FACILITATION; FEMALE; HUMAN; INHIBITION (PSYCHOLOGY); MALE; MOTOR CORTEX; NERVE CELL EXCITABILITY; NERVE CONDUCTION; OUTCOME ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT DURATION;

AGED; ANTIPARKINSON AGENTS; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; MOTOR CORTEX; PARKINSON DISEASE; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84873734251     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2012.08.012     Document Type: Article

References (32)

1. Picconi B., Centonze D., Hakansson K., Bernardi G., Greengard P., Fisone G., et al. Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat Neurosci 2003, 6:501-506.
2. Kishore A., Popa T., Velayudhan B., Joseph T., Balachandran A., Meunier S. Acute dopamine boost has a negative effect on plasticity of the primary motor cortex in advanced Parkinson's disease. Brain 2012, 135:2024-2088.
3. Morgante F., Espay A.J., Gunraj C., Lang A.E., Chen R. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias. Brain 2006, 129:1059-1069.
4. Huang Y.Z., Rothwell J.C., Lu C.S., Chuang W.L., Chen R.S. Abnormal bidirectional plasticity-like effects in Parkinson's disease. Brain 2011, 134:2312-2320.
5. Cantello R., Tarletti R., Civardi C. Transcranial magnetic stimulation and Parkinson's disease. Brain Res Rev 2002, 38:309-327.
6. Nakashima K., Wang Y., Shimoda M., Sakuma K., Takahashi K. Shortened silent period produced by magnetic cortical stimulation in patients with Parkinson's disease. J Neurol Sci 1995, 130:209-214.
7. Ziemann U. TMS and drugs. Clin Neurophysiol 2004, 115:1717-1729.
8. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatr 1992, 55:181-184.
9. Marconi R., Lefebvre-Caparros D., Bonnet A.M., Vidailhet M., Dubois B., Agid Y. Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology. Mov Disord 1994, 9:2-12.
10. Kujirai T., Caramia M.D., Rothwell J.C., Day B.L., Thompson P.D., Ferbert A., et al. Corticocortical inhibition in human motor cortex. J Physiol 1993, 471:501-519.
11. Ridding M.C., Inzelberg R., Rothwell J.C. Changes in excitability of motor cortical circuitry in patients with Parkinson's disease. Ann Neurol 1995, 37:181-188.
12. Inghilleri M., Berardelli A., Marchetti P., Manfredi M. Effects of diazepam, baclofen and thiopental on the silent period evoked by transcranial magnetic stimulation in humans. Exp Brain Res 1996, 109:467-472.
13. Pierantozzi M., Palmieri M.G., Marciani M.G., Bernardi G., Giacomini P., Stanzione P. Effect of apomorphine on cortical inhibition in Parkinson's disease patients: a transcranial magnetic stimulation study. Exp Brain Res 2001, 141:52-62.
14. Cantello R., Gianelli M., Bettucci D., Civardi C., De Angelis M.S., Mutani R. Parkinson's disease rigidity: magnetic motor evoked potentials in a small hand muscle. Neurology 1991, 41:1449-1456.
15. Priori A., Berardelli A., Inghilleri M., Accornero N., Manfredi M. Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism. Brain 1994, 117:317-323.
16. Berardelli A., Rona S., Inghilleri M., Manfredi M. Cortical inhibition in Parkinson's disease. A study with paired magnetic stimulation. Brain 1996, 119:71-77.
17. Strafella A.P., Valzania F., Nassetti S.A., Tropeani A., Bisulli A., Santangelo M., et al. Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson's disease: a transcranial magnetic stimulation study. Clin Neurophysiol 2000, 111:1198-1202.
18. Pierantozzi M., Marciani M.G., Palmieri M.G., Brusa L., Galati S., Caramia M.D., et al. Effect of vigabatrin on motor responses to transcranial magnetic stimulation: an effective tool to investigate in vivo GABAergic cortical inhibition in humans. Brain Res 2004, 1028:1-8.
19. Dauper J., Peschel T., Schrader C., Kohlmetz C., Joppich G., Nager W., et al. Effects of subthalamic nucleus (STN) stimulation on motor cortex excitability. Neurology 2002, 59:700-706.
20. Reynolds C., Ashby P. Inhibition in the human motor cortex is reduced just before a voluntary contraction. Neurology 1999, 53:730-735.
21. Buccolieri A., Abbruzzese G., Rothwell J.C. Relaxation from a voluntary contraction is preceded by increased excitability of motor cortical inhibitory circuits. J Physiol 2004, 558:685-695.
22. Sohn Y.H., Wiltz K., Hallett M. Effect of volitional inhibition on cortical inhibitory mechanisms. J Neurophysiol 2002, 88:333-338.
23. Liepert J., Classen J., Cohen L.G., Hallett M. Task-dependent changes of intracortical inhibition. Exp Brain Res 1998, 118:421-426.
24. Stinear C.M., Byblow W.D. Role of intracortical inhibition in selective hand muscle activation. J Neurophysiol 2003, 89:2014-2020.
25. Papa S.M., Chase T.N. Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys. Ann Neurol 1996, 39:574-578.
26. Turjanski N., Lees A.J. Gamma vinyl GABA in the treatment of levodopa-induced dyskinesias in Parkinson's disease. J Neurol Neurosurg Psychiatr 1992, 55:413.
27. Bares M., Kanovsky P., Klajblova H., Rektor I. Intracortical inhibition and facilitation are impaired in patients with early Parkinson's disease: a paired TMS study. Eur J Neurol 2003, 10:385-389.
28. Valzania F., Quatrale R., Strafella A.P., Bombardi R., Santangelo M., Tassinari C.A., et al. Pattern of motor evoked response to repetitive transcranial magnetic stimulation. Electroencephalogr Clin Neurophysiol 1994, 93:312-317.
29. Sanger T.D., Garg R.R., Chen R. Interactions between two different inhibitory systems in the human motor cortex. J Physiol 2001, 530:307-317.
30. Nakamura H., Kitagawa H., Kawaguchi Y., Tsuji H. Intracortical facilitation and inhibition after transcranial magnetic stimulation in conscious humans. J Physiol 1997, 498:817-823.
31. Nutt J.G., Carter J.H., Woodward W.R. Long-duration response to levodopa. Neurology 1995, 45:1613-1616.
32. Zappia M., Colao R., Montesanti R., Rizzo M., Aguglia U., Gambardella A., et al. Long-duration response to levodopa influences the pharmacodynamics of short-duration response in Parkinson's disease. Ann Neurol 1997, 42:245-248.